[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100566102":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":35,"responsibleParty":62,"collaborators":65,"id":71,"slug":11,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":76,"eligibilityCriteria":77,"healthyVolunteers":72,"sex":78,"minAge":79,"maxAge":11,"enrollmentInfo":80,"targetDuration":11,"studyType":83,"phases":84,"briefSummary":86,"conditions":87,"keywords":11,"overallStatus":38,"whyStopped":11,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"Versailles Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with sickle cell disease","EXPERIMENTAL",null,[13],"Other: Drépa-FACETS Program",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":11},"Drépa-FACETS Program","Drépa-FACETS Program for Sickle Cell Disease",[9],[20],{"name":21,"affiliation":22,"role":23},"Marie-Claire GAY, Pr","Paris Nanterre University","STUDY_DIRECTOR",[25,31],{"name":26,"role":27,"phone":28,"phoneExt":29,"email":30},"Michalina DANNOUNE","CONTACT","0139638856","+33","mdannoune@ght78sud.fr",{"name":32,"role":27,"phone":33,"phoneExt":29,"email":34},"Damien OUDIN-DOGLIONI, PhD","0476748839","damien.oudin-doglioni@univ-grenoble-alpes.fr",[36,52],{"facility":37,"status":38,"city":39,"state":11,"zip":40,"country":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"CHU Grenoble Alpes","RECRUITING","Grenoble","38000","France",{"type":43,"coordinates":44},"Point",[45,46],5.71479,45.17869,{"lat":46,"lon":45},[49],{"name":50,"role":27,"phone":11,"phoneExt":11,"email":51},"Caroline MAKOWSKI, PhD","CMakowski@chu-grenoble.fr",{"facility":53,"status":54,"city":55,"state":11,"zip":56,"country":41,"cosmosGeoPoint":57,"geoPoint":61,"contacts":11},"Hospital Versailles","COMPLETED","Le Chesnay","78150",{"type":43,"coordinates":58},[59,60],2.12213,48.8222,{"lat":60,"lon":59},{"type":63,"investigatorFullName":26,"investigatorTitle":64,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Investigator Coordonnator",[66,68,70],{"name":67,"class":6},"University Hospital, Grenoble",{"name":69,"class":6},"University Grenoble Alps",{"name":22,"class":6},"100566102",false,"NCT06650813","Adapting the FACETS Program to Sickle Cell Disease","Adapting the FACETS Fatigue Management Program to Sickle Cell Disease","Drépa-FACETS","Inclusion Criteria:\n\n* Participant having freely given his oral agreement.\n* Participant with a major sickle cell syndrome, regardless of genotype (e.g. SS, SC, Sbeta).\n* Participant with a sufficient command of spoken and written French to take the assessments, complete the questionnaires, follow the program sessions and carry out the home exercises.\n\nExclusion Criteria:\n\n* Participant with one or more severe psychiatric pathologies (e.g. severe depression, psychosis) that could interfere with the conduct of the study, in particular the primary and secondary endpoints.\n* Participants with another chronic pathology causing fatigue.\n* Participants in vaso-occlusive crisis (VOC) or hospitalization.\n* Participant under legal protection (guardianship, curatorship, safeguard of justice, deprived of liberty).","ALL","18 Years",{"count":81,"type":82},24,"ESTIMATED","INTERVENTIONAL",[85],"NA","Adaptation of a fatigue management program combining the principles of cognitive-behavioral therapy and energy conservation strategies (FACETS program) for a population of adult patients with sickle cell disease (Drépa-FACETS program).",[88,89],"Fatigue Symptom","Sickle Cell Disease","2025-08-14",{"date":92,"type":93},"2025-08-19","ACTUAL",{"date":95,"type":93},"2025-01-10",{"date":97,"type":82},"2026-05-02",{"name":5,"class":6},2]